Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» mRNA-1020
mRNA-1020
Moderna Announces First Participants Dosed in Phase 1/2 Study with mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccine Candidates
Yahoo Finance
Mon, 04/11/22 - 10:29 am
Moderna Therapeutics
vaccines
clinical trials
mRNA-1020
mRNA-1030
Flu
flu vaccines
